top of page
myengene-2d-image-07.jpg

The Beginning of Personalized Preventative Medicine
Right Drug, Right Dose, Right Now!

VISION

MyEngene is an “Engine” for your genes.

Addressing the 4th leading cause of death in the USA. By analyzing genetic profiles, we can assess the effectiveness of prescribed drugs.

 

An individual’s unique DNA can make some medications ineffective or dangerous. The only way to know which medications are safe is through a genomic test and advanced analysis. MyEngene started with a vision to truly personalize medicine. Our mission is to create a positive healthcare experience by elevating the standard of care that patients deserve.

THE BEGINNING OF PERSONALIZED PREVENTATIVE MEDICINE

 Right Drug, Right Dose, Right Now! 

VISION

MyEngene is an “Engine” for your genes.

Adverse Drug Reactions is the 4th leading cause of death in the USA. By analyzing genetic profiles, we can assess the effectiveness of prescribed drugs.

 

An individual’s unique DNA can make some medications ineffective or dangerous. The only way to know which medications are safe is through a genomic test and advanced analysis. MyEngene started with a vision to truly personalize medicine. Our mission is to create a positive healthcare experience by elevating the standard of care that patients deserve.

myengene-2d-image-01.jpg

PHARMACOGENOMICS PROBLEMS

ADR

There is a lack of use and understanding of genomics to help prescribe the right medicine andreduce hospitalizations and deaths.

128,000 Americans die each year from ADR’s (adverse drug reactions) and their side effects.

We can reduce Adverse Drug Reaction pain and suffering and reduce costs by 95%.

 

Pharmacogenomics uses information about a person’s genetic makeup, or genome, to choose the drugs and doses that are likely to work best for that particular person. This growing field combines the sciences of pharmacology and genomics.

PHARMACOGENOMICS PROBLEMS

ADR

There is a lack of use and understanding of genomics to help prescribe the right medicine andreduce hospitalizations and deaths.

128,000 Americans die each year from ADR’s (Adverse Drug Reactions) and their side effects.

We can reduce Adverse Drug Reaction pain and suffering and reduce costs by 95%.

 

Pharmacogenomics uses information about a person’s genetic makeup, or genome, to choose the drugs and doses that are likely to work best for that particular person. This growing field combines the sciences of pharmacology and genomics.

ENGLISH

SPANISH

PERSONALIZED

ADR’s send millions to the ER, urgent care centers, and their own doctors every year. Here at MyEngene, we want to personalize your medicine, translating your genome into clinically meaningful information. Our technology has the potential to transform how we think about, diagnose, and treat health issues.

PROACTIVE

After a few seconds of processing, you or your physician will receive guidelines that optimize your prescription drugs. Our platform is continuously learning and adapting, using artificial intelligence and cloud-based software to provide actionable information.

PREVENTATIVE

Not all prescription drugs are safe for everyone. 97% of us have genetic variants that can cause a normally safe drug to be ineffective, or even deadly. These variants cannot be reliably identified by family history, blood tests or other routine methods. MyEngene provides doctors with a clinical tool to suggest better treatment and therapies.

wireframe-dna-molecules-structure-mesh-from-starry.jpg

TAKE ACTION BASED ON YOUR DNA!
Immediate Results!

Get Personalized Medicine that is Proactive and Preventative

MyEngene’s results come with clear next steps, so you know how to improve your health.

We also make it easy to share with your doctor, so that you can work together to develop a plan that’s personalized to your body’s needs.

How It Works

How It Works

genomics.png

ACQUIRE GENOME IN DIGITAL FORMAT

analyze.png

ANALYZE GENOME SEQUENCE

booking.png

FILE UPLOADED AT MYENGENE

report.png

GET REPORTS AND UPDATES

Birth Control Pills
myengene-2d-image-08.jpg

News & Events

bottom of page